Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in dermatomyositis and antisynthetase syndrome, expected to initiate ...
Day One Biopharmaceuticals (NASDAQ:DAWN) executives highlighted accelerating commercial momentum for OJEMDA and outlined ...
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results ...
Major stock indexes fell Friday to post losses for a second straight week after a weak jobs report, while oil futures soared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results